NovaSight

NovaSight is an Israeli medical technology company founded in 2016, dedicated to enhancing pediatric vision care through innovative digital solutions that utilize eye tracking and artificial intelligence. The company focuses on developing products for the assessment and treatment of early vision disorders in children, aiming to modernize traditional eye care practices. Among its flagship offerings is CureSight, an eye tracking-based treatment system for amblyopia, which serves as a digital alternative to conventional eye patching therapy. Another key product is EyeSwift®Pro, a vision assessment device that quickly screens for multiple vision impairments, enabling early detection and diagnosis. NovaSight is also working on pipeline products like ActiveGlass®, a wearable solution for myopia control, and TrackSight, a software platform for real-time visual health monitoring. With a management team experienced in optics, medical devices, and neuroscience, NovaSight primarily serves pediatric patients and healthcare providers. The company is headquartered in Israel and has a presence in France, reflecting its commitment to advancing vision care technologies.

• Employees 14
• Founded 2016
• Annual Revenue $3000000
• Total Funding $8000000